News

The US Oncology Network Hosts Second Annual Boot Camp Focusing on New Value-Based Care and Payment Models

June 23, 2017

Intensive workshop provided resources, expertise to help practices succeed with the Oncology Care Model, MIPS and other alternative payment programs

Read More

McKesson Specialty Health and The US Oncology Network Expand Agreement with The National Comprehensive Cancer Network, Adding New Disease States to Value Pathways

June 14, 2017

Expanded agreement enhances Value Pathways, providing physicians access to the most recent evidence available for five additional disease states

Read More

Arizona Oncology Opens State-of-the-Art Cancer Treatment Center at ASU Research Park

June 13, 2017

New facility developed by Ryan Companies US, Inc. offers leading-edge cancer care to growing East Valley region

Tempe, Ariz. (June 13, 2017) — Arizona Oncology’s new state-of-the-art cancer treatment center, located at the Arizona State University Research Park (ASURP), is now open and offering the latest cancer treatment services available to patients in Phoenix and the East Valley. The new center, developed and built by Ryan Companies US, Inc., offers integrated, high-quality care to diagnose and treat cancer. Patient services include medical, gynecologic and radiation oncology, hematology, advanced diagnostics including PET/CT imaging, supportive care services, and clinical trials. The practice is also offering the latest treatment options for patients, including immuno-oncology, bio markers, and targeted therapies.

Read More

Virginia Cancer Specialists Opens New Research Facility for Phase I Clinical Trials, Leading the Region in Advanced Cancer Research

June 8, 2017

New clinic enhances world-class research program by strengthening Phase I capabilities

Fairfax, Va. (June 8, 2017) There is good news today for patients in Northern Virginia who are battling cancer, as well as those who may face the disease in the future. Virginia Cancer Specialists (VCS), Northern Virginia’s premier cancer care and research center with more than 40 years of service to patients and a practice in The US Oncology Network, has opened a new state-of-the-art research clinic in Fairfax, Virginia dedicated exclusively to Phase I clinical trials. A ribbon cutting ceremony was held May 24 to officially mark the opening.

Read More

Community Oncologists from The US Oncology Network and US Oncology Research Share Meaningful Research and Visionary Thinking During American Society of Clinical Oncology Annual Meeting

May 31, 2017

Approximately 40 abstracts accepted for presentation, highlighting the importance of community-based cancer research in developing new and novel cancer fighting therapies in areas like hematology, breast cancer, and immuno-oncology

Debra Patt, MD, MBA, MPH, to speak during an Educational Session on creating an informatics-driven oncology practice

Read More

McKesson Specialty Health Selected by TESARO to provide ZEJULA (niraparib), Approved for the Treatment of Recurrent Ovarian Cancer

May 12, 2017

The Woodlands, Texas (May 12, 2017)McKesson Specialty Health, a division of McKesson Corporation that works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, has played a significant role in the recent approval of ZEJULATM (niraparib). Approximately ten practices affiliated with US Oncology Research, one of the largest community-based oncology research programs in the United States supported by McKesson Specialty Health, participated in the clinical trial that led to approval by the U.S. Food and Drug Administration (FDA) on March 27, 2017. ZEJULA marks the 66th FDA approval in which US Oncology Research has contributed.

Read More

Thought Leaders from McKesson Specialty Health and The US Oncology Network Are Key Presenters at the 2017 Community Oncology Conference

April 27, 2017

Presentations will focus on innovative solutions for community oncology success and cancer care delivery in today’s challenging environment

Read More

US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months

April 25, 2017

Program reaches recruitment milestone while bringing novel treatments to community cancer centers

The Woodlands, Texas (April 25, 2017)US Oncology Research, one of the largest community-based oncology research programs in the United States, enrolled more than 2,900 subjects into clinical trials during the fiscal year ended March 31, 2017. The participation of these patients in leading-edge oncology trials for a wide range of cancer types contributed to eight cancer therapies receiving FDA approvals, making promising new treatments available to cancer patients across the nation. Contributing to so many FDA approvals in one fiscal year is unprecedented for US Oncology Research and demonstrates the organization’s strong ongoing commitment to play a vital role in understanding cancer and identifying effective therapies. In total, US Oncology Research has enrolled more than 66,000 patients into clinical trials since its inception in 1992.

Read More

Medical Oncology Hematology Consultants Joins The US Oncology Network

March 1, 2017

Practice with largest infusion treatment center in Delaware gains access to world-class treatments and enhances its cutting-edge research program

Read More

Black Book Research Recognizes iKnowMed as the Number One Ranked Oncology Electronic Health Record for Sixth Consecutive Year

February 28, 2017

Number One Rankings in Key Performance Areas Reinforces McKesson Specialty Health’s Leading Position in the Oncology and Hematology Market

The Woodlands, Texas (Feb. 28, 2017) — For the sixth year in a row, iKnowMedSM electronic health record (EHR) has been named the top-ranked EHR platform for oncologists and hematologists by Black BookTM Research, an unbiased industry-leading source for polling, surveys and market research. iKnowMed was recognized for its superior focus on meeting the unique needs of community-based oncology practices.

Read More

McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit

February 2, 2017

The Woodlands, Texas (February 2, 2017) — Representatives from McKesson Specialty Health and The US Oncology Network (The Network) will be presenting at the 10th Cancer Center Business Summit, which will be held Monday and Tuesday, February 6-7 at The Aria Resort in Las Vegas, Nevada. The Summit aims to showcase innovative organizations and how they are responding to changes occurring in the cancer care marketplace.

Read More

Southern Cancer Center Joins The US Oncology Network

February 1, 2017

Affiliation with the largest network of its kind strengthens Southern Cancer Center’s ability to remain independent, providing access to vast resources to enhance care

Read More

Vantage Oncology’s 50 centers and more than 350 affiliated physicians join The US Oncology Network

January 26, 2017

The Woodlands, Texas (January 26, 2017) - The US Oncology Network (“The Network”) announced today, as part of McKesson Specialty Health’s ongoing integration with Vantage Oncology, that 50 centers in 13 states and more than 350 affiliated physicians have joined The Network.

The US Oncology Network provides effective and comprehensive practice management capabilities and value-based care expertise critical for navigating today’s challenging healthcare landscape. The Network is supported by McKesson Specialty Health, an industry leader that works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care.

Read More

McKesson Specialty Health and The US Oncology Network invited to participate in the final White House “Making Health Care Better” Series focused on Community Oncology

January 11, 2017

Dr. Debra Patt shared expertise on the event’s Support Services and Survivorship Panel

The Woodlands, Texas (January 11, 2017) — Representatives from McKesson Specialty Health and The US Oncology Network (The Network) were invited to participate in a community oncology event as part of the White House “Making Health Care Better” Series, which highlights progress made in improving the health system over the past eight years. The President’s Health Policy Team collaborated with the Cancer Moonshot program to host the event and put a spotlight on the role and importance of community oncology in cancer care. The event was held on Wednesday, January 11 from 8am to 12pm ET at the White House and was only open to invited attendees.

Read More

McKesson Specialty Health Expands Operations with New Office in Downtown Evansville, Indiana

December 13, 2016

When Fully Staffed, the McKesson Specialty Health Indiana Regional Billing Office will Employ More than 100

EVANSVILLE, Indiana (December 13, 2016) — Evansville Mayor Lloyd Winnecke and McKesson Specialty Health announced that McKesson will expand its Revenue Cycle Services operations with the opening of a new office in Evansville, Indiana in early 2017. When fully staffed, the new McKesson Specialty Health Indiana Regional Billing Office will employ more than 100.

“I am excited that McKesson Specialty Health has chosen Evansville to locate this new office and create additional jobs for the City and the region,” said Mayor Winnecke. “This reinforces our focus and efforts of fostering job creation and business growth, and I expect McKesson’s industry leadership will serve as an invaluable contribution to the Indiana economy.”

Read More

US Oncology Research Annual Science Forum focuses on delivering the latest research opportunities to patients in the community setting

December 8, 2016

15th Annual Science Forum promotes clinical research education, innovation and collaboration

The Woodlands, Texas (December 8, 2016)US Oncology Research held its 15th Annual Science Forum earlier this fall. The annual meeting for all US Oncology Research affiliated investigators was held in Dallas and highlighted the importance of clinical trials as a treatment option for cancer patients.

“A clinical trial saved my life,” said Rhonda Jenkins, breast cancer survivor, clinical trial participant and patient of Texas Oncology, an affiliate of US Oncology Research.

Read More

Blood & Cancer Center Joins Florida Cancer Affiliates

December 1, 2016

Collaboration strengthens both practices, enhancing patient care, research opportunities and access to services throughout Northern Florida

Ocala, Fla. (December 1, 2016) — Florida Cancer Affiliates (FCA), a premier provider of advanced cancer care services in Florida, announced that Blood & Cancer Center has joined its practice. Anju Vasudevan, M.D., and Cecil Robertson, M.D., oncologists and hematologists with Blood & Cancer Center, will unite with Florida Cancer Affiliate’s group of physicians to provide comprehensive state-of-the-art cancer care in convenient, patient-friendly community settings. FCA is an affiliate of The US Oncology Network (The Network), one of the nation’s largest networks of integrated community-based oncology practices.

Read More

US Oncology Research Announces Schedule of Presentations at the 2016 American Society of Hematology Annual Meeting and Exposition

November 30, 2016

Sixteen presentations on clinical research conducted by top US Oncology Research affiliated investigators will take place at ASH 2016

The Woodlands, Texas (November 30, 2016) — More than 20 leading investigators affiliated with US Oncology Research participated in sixteen studies that will be presented at the 58th American Society of Hematology Annual Meeting and Exposition (ASH), a premier scientific event in malignant and non-malignant hematology, held December 3-6 in San Diego. Six oral and ten poster presentations co-authored by US Oncology Research affiliated investigators cover topics such as diffuse large B-cell lymphoma (DLBCL), multiple myeloma, small lymphocytic leukemia, and mantle cell lymphoma.

Read More

Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors

November 15, 2016

Denver, Colo. (November 15, 2016) – Rocky Mountain Cancer Centers (RMCC), a practice in The US Oncology Network, is the first in the Rocky Mountain region, and one of only a handful of sites in the United States, to offer the newly approved Ga-68 DOTATATE PET/CT for patients with neuroendocrine tumors (NETs). The U.S. Food and Drug Administration (FDA) recently approved the test. Marketed under the name Netspot™, gallium 68 DOTATATE is a radioactive diagnostic agent used in positron emission tomography (PET) imaging. Because the gallium DOTATATE binds strongly to the receptors of neuroendocrine tumor cells, it effectively detects tumors and metastases, not seen on other standard scans, and reveals the locations of tumors.

Read More

Lancet Oncology Multi-Part Study on Oncology Drug Safety in the 21st Century Reveals the Need for New Approaches to Biosimilar and Generic Oncology Drugs

November 2, 2016

Much reform is needed before these new oncology drugs are safe, effective, affordable choices for U.S. patients

Read More

Pages